<!DOCTYPE html> <html> <head> <meta charset="utf-8" /> <meta http-equiv="X-UA-Compatible" content="IE=edge" /> <meta name="viewport" content="width=device-width, initial-scale=1" /> <meta name="description" content="A blank page." /> <meta name="twitter:card" content="summary" /> <meta name="twitter:site" content="@" /> <meta name="twitter:title" content="TITLE" /> <meta name="twitter:description" content="A blank page." /> <meta name="twitter:image" content="http://localhost:4000/media/thumb-big.jpg" /> <meta property="og:site_name" content="CoV Index"/> <meta property="og:type" content="website"/> <meta property="og:title" content="CoV IndexTITLE"/> <meta property="og:description" content="A blank page."/> <meta property="og:url" content="http://localhost:4000/blank.html"/> <meta property="og:image" content="http://localhost:4000/media/thumb-big.jpg"/> <link rel="sitemap" href="/sitemap.xml" /> <link rel="canonical" href="http://localhost:4000/blank.html" /> <link rel="alternate" type="application/rss+xml" title="CoV Index" href="http://localhost:4000/blog/feed.xml" /> <title>CoV Index - TITLE</title> <style> body,h1,h2,h3,h4,h5,h6,p,blockquote,pre,hr,dl,dd,ol,ul,figure{margin:0;padding:0}body{font:400 16px/1.5 "Helvetica Neue",Helvetica,Arial,sans-serif;color:#111;background-color:#fdfdfd;-webkit-text-size-adjust:100%;-webkit-font-feature-settings:"kern" 1;-moz-font-feature-settings:"kern" 1;-o-font-feature-settings:"kern" 1;font-feature-settings:"kern" 1;font-kerning:normal}h1,h2,h3,h4,h5,h6,p,blockquote,pre,ul,ol,dl,figure,.highlight{margin-bottom:15px}img{max-width:100%;vertical-align:middle}figure>img{display:block}figcaption{font-size:14px}ul,ol{margin-left:30px}li>ul,li>ol{margin-bottom:0}h1,h2,h3,h4,h5,h6{font-weight:400}a{color:#2a7ae2;text-decoration:none}a:visited{color:#1756a9}a:hover{color:#111;text-decoration:underline}blockquote{color:#828282;border-left:4px solid #e8e8e8;padding-left:15px;font-size:18px;letter-spacing:-1px;font-style:italic}blockquote>:last-child{margin-bottom:0}pre,code{font-size:15px;border:1px solid #e8e8e8;border-radius:3px;background-color:#eef}code{padding:1px 5px}pre{padding:8px 12px;overflow-x:auto}pre>code{border:0;padding-right:0;padding-left:0}.wrapper{max-width:-webkit-calc(800px - (30px * 2));max-width:calc(800px - (30px * 2));margin-right:auto;margin-left:auto;padding-right:30px;padding-left:30px}@media screen and (max-width: 800px){.wrapper{max-width:-webkit-calc(800px - (30px));max-width:calc(800px - (30px));padding-right:15px;padding-left:15px}}.wrapper:after,.footer-col-wrapper:after{content:"";display:table;clear:both}.icon>svg{display:inline-block;width:16px;height:16px;vertical-align:middle}.icon>svg path{fill:#828282}.site-header{border-top:5px solid #424242;border-bottom:1px solid #e8e8e8;min-height:56px;position:relative}.site-title{font-size:26px;font-weight:300;line-height:56px;letter-spacing:-1px;margin-bottom:0;float:left}.site-title,.site-title:visited{color:#424242}.site-nav{float:right;line-height:56px}.site-nav .menu-icon{display:none}.site-nav .page-link{color:#111;line-height:1.5}.site-nav .page-link:not(:last-child){margin-right:20px}@media screen and (max-width: 600px){.site-nav{position:absolute;top:9px;right:15px;background-color:#fdfdfd;border:1px solid #e8e8e8;border-radius:5px;text-align:right}.site-nav .menu-icon{display:block;float:right;width:36px;height:26px;line-height:0;padding-top:10px;text-align:center}.site-nav .menu-icon>svg{width:18px;height:15px}.site-nav .menu-icon>svg path{fill:#424242}.site-nav .trigger{clear:both;display:none}.site-nav:hover .trigger{display:block;padding-bottom:5px}.site-nav .page-link{display:block;padding:5px 10px;margin-left:20px}.site-nav .page-link:not(:last-child){margin-right:0}}.site-footer{border-top:1px solid #e8e8e8;padding:30px 0}.footer-heading{font-size:18px;margin-bottom:15px}.contact-list,.social-media-list{list-style:none;margin-left:0}.footer-col-wrapper{font-size:15px;color:#828282;margin-left:-15px}.footer-col{float:left;margin-bottom:15px;padding-left:15px}.footer-col-1{width:-webkit-calc(35% - (30px / 2));width:calc(35% - (30px / 2))}.footer-col-2{width:-webkit-calc(20% - (30px / 2));width:calc(20% - (30px / 2))}.footer-col-3{width:-webkit-calc(45% - (30px / 2));width:calc(45% - (30px / 2))}@media screen and (max-width: 800px){.footer-col-1,.footer-col-2{width:-webkit-calc(50% - (30px / 2));width:calc(50% - (30px / 2))}.footer-col-3{width:-webkit-calc(100% - (30px / 2));width:calc(100% - (30px / 2))}}@media screen and (max-width: 600px){.footer-col{float:none;width:-webkit-calc(100% - (30px / 2));width:calc(100% - (30px / 2))}}.page-content{padding:30px 0}.page-heading{font-size:20px}.post-list{margin-left:0;list-style:none}.post-list>li{margin-bottom:30px}.post-meta{font-size:14px;color:#828282}.post-link{display:block;font-size:24px}.post-header{margin-bottom:30px}.post-title{font-size:42px;letter-spacing:-1px;line-height:1}@media screen and (max-width: 800px){.post-title{font-size:36px}}.post-content{margin-bottom:30px}.post-content h2{font-size:32px}@media screen and (max-width: 800px){.post-content h2{font-size:28px}}.post-content h3{font-size:26px}@media screen and (max-width: 800px){.post-content h3{font-size:22px}}.post-content h4{font-size:20px}@media screen and (max-width: 800px){.post-content h4{font-size:18px}}.highlight{background:#fff}.highlighter-rouge .highlight{background:#eef}.highlight .c{color:#998;font-style:italic}.highlight .err{color:#a61717;background-color:#e3d2d2}.highlight .k{font-weight:bold}.highlight .o{font-weight:bold}.highlight .cm{color:#998;font-style:italic}.highlight .cp{color:#999;font-weight:bold}.highlight .c1{color:#998;font-style:italic}.highlight .cs{color:#999;font-weight:bold;font-style:italic}.highlight .gd{color:#000;background-color:#fdd}.highlight .gd .x{color:#000;background-color:#faa}.highlight .ge{font-style:italic}.highlight .gr{color:#a00}.highlight .gh{color:#999}.highlight .gi{color:#000;background-color:#dfd}.highlight .gi .x{color:#000;background-color:#afa}.highlight .go{color:#888}.highlight .gp{color:#555}.highlight .gs{font-weight:bold}.highlight .gu{color:#aaa}.highlight .gt{color:#a00}.highlight .kc{font-weight:bold}.highlight .kd{font-weight:bold}.highlight .kp{font-weight:bold}.highlight .kr{font-weight:bold}.highlight .kt{color:#458;font-weight:bold}.highlight .m{color:#099}.highlight .s{color:#d14}.highlight .na{color:teal}.highlight .nb{color:#0086B3}.highlight .nc{color:#458;font-weight:bold}.highlight .no{color:teal}.highlight .ni{color:purple}.highlight .ne{color:#900;font-weight:bold}.highlight .nf{color:#900;font-weight:bold}.highlight .nn{color:#555}.highlight .nt{color:navy}.highlight .nv{color:teal}.highlight .ow{font-weight:bold}.highlight .w{color:#bbb}.highlight .mf{color:#099}.highlight .mh{color:#099}.highlight .mi{color:#099}.highlight .mo{color:#099}.highlight .sb{color:#d14}.highlight .sc{color:#d14}.highlight .sd{color:#d14}.highlight .s2{color:#d14}.highlight .se{color:#d14}.highlight .sh{color:#d14}.highlight .si{color:#d14}.highlight .sx{color:#d14}.highlight .sr{color:#009926}.highlight .s1{color:#d14}.highlight .ss{color:#990073}.highlight .bp{color:#999}.highlight .vc{color:teal}.highlight .vg{color:teal}.highlight .vi{color:teal}.highlight .il{color:#099}.zoomify{cursor:pointer;cursor:-webkit-zoom-in;cursor:zoom-in}.zoomify.zoomed{cursor:-webkit-zoom-out;cursor:zoom-out;padding:0;margin:0;border:none;border-radius:0;box-shadow:none;position:relative;z-index:1501}.zoomify-shadow{position:fixed;top:0;left:0;right:0;bottom:0;width:100%;height:100%;display:block;z-index:1500;background:rgba(0,0,0,0.3);opacity:0}.zoomify-shadow.zoomed{opacity:1;cursor:pointer;cursor:-webkit-zoom-out;cursor:zoom-out}.share-button{border:1px solid gray;padding:3px;font-size:10pt;background:#f0f0f0;color:#000;-moz-border-radius:4px;border-radius:4px;margin-right:1em}.share-button:visited{color:#000}.share-button:hover{text-decoration:none;background:#dcdcdc}.share-button .icon{vertical-align:text-bottom}.social{margin-bottom:1em}.footer-col-2{text-align:right}.aside{float:right;width:15em;font-style:italic;border:1px dotted;background:1px dotted;padding:1em;margin-left:1em;margin-top:1em;margin-bottom:1em}#content-license{font-size:8pt;text-align:center}@media screen and (max-width: 600px){#account_name_query{width:5em}#example_list li{display:list-item !important}#board{width:18em}.footer-col-2{text-align:left}.aside{float:none;margin:0px auto;width:90%;margin-bottom:2em}}.var{display:table-cell;width:7em;font-weight:bold}.value{display:table-cell}.search-result{color:darkslategray;font-size:1.3em}.search-result:visited{color:gray}#results{list-style:none;margin-left:0}#search,#search_button{font-size:2em;vertical-align:bottom}#search{width:7em}.lds-circle{display:block;transform:translateZ(1px);margin:0 auto}.lds-circle>div{display:block;width:64px;height:64px;margin:8px;border-radius:50%;background:lightgray;animation:lds-circle 4s cubic-bezier(0, 0.2, 0.8, 1) infinite}@keyframes lds-circle{0%, 100%{animation-timing-function:cubic-bezier(0.5, 0, 1, 0.5)}0%{transform:rotateY(0deg)}50%{transform:rotateY(1800deg);animation-timing-function:cubic-bezier(0, 0.5, 0.5, 1)}100%{transform:rotateY(3600deg)}}.keyword{display:inline-block;margin:0.25em 0.5em 0.25em 0;padding:0.25em;border:1px dotted gray}.keyword:hover{background:lightgray} </style> <script src="/js/main.js"></script> </head> <body> <header class="site-header"> <div class="wrapper"> <a class="site-title" href="/"><img width="24" height="24" src="data:image/png;base64,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" /> CoV Index</a> <nav class="site-nav"> <a href="#" class="menu-icon"> <svg viewBox="0 0 18 15"> <path fill="#424242" d="M18,1.484c0,0.82-0.665,1.484-1.484,1.484H1.484C0.665,2.969,0,2.304,0,1.484l0,0C0,0.665,0.665,0,1.484,0 h15.031C17.335,0,18,0.665,18,1.484L18,1.484z"/> <path fill="#424242" d="M18,7.516C18,8.335,17.335,9,16.516,9H1.484C0.665,9,0,8.335,0,7.516l0,0c0-0.82,0.665-1.484,1.484-1.484 h15.031C17.335,6.031,18,6.696,18,7.516L18,7.516z"/> <path fill="#424242" d="M18,13.516C18,14.335,17.335,15,16.516,15H1.484C0.665,15,0,14.335,0,13.516l0,0 c0-0.82,0.665-1.484,1.484-1.484h15.031C17.335,12.031,18,12.696,18,13.516L18,13.516z"/> </svg> </a> <div class="trigger"> <a class="page-link" href="/about/">About</a> <a class="page-link" href="/bibtex/">BibTeX</a> <a class="page-link" href="/blog/">Blog</a> <a class="page-link" href="/topics/">Topics</a> </div> </nav> </div> </header> <div class="page-content"> <div class="wrapper"> 


<article class="post">

    <header class="post-header">
      <h1 class="post-title">üìÑ Laboratory Experiments on Oral Vaccination of Calves against Rotavirus or Coronavirus induced Diarrhoea</h1>
    </header>
  
    <div class="post-content">

        <div class="home">

            <div style="margin-bottom: 1em;">
                The efficacy of oral vaccination of calves with a modified live virus vaccine (Scour‚Äêvax¬Æ‚Äê2, Smith Kline) against rotavirus and/or coronavirus induced diarrhoea was examined under controlled conditions. Calves were vaccinated one hour after the first feed. Challenge was done orally with a mixture of virulent bovine rotavirus and bovine coronavirus. In the first experiments calves received colostrum free of antibodies against these viruses. Three control calves, challenged on the sixth day of life, developed severe diarrhoea after two to three days. Diarrhoea lasted for five to twelve days and on average the calves lost 12.5 per cent body weight. Rotavirus and coronavirus shedding was found in all three. In contrast, no diarrhoea was observed in two vaccinated calves challenged on day 6. After vaccination one shed rotavirus and one rotavirus plus coronavirus, but no virus excretion was found after the challenge. Three other vaccinated calves, that were not held completely isolated, all developed diarrhoea within three days, i.e. before the experimental challenge was performed. In each calf the beginning of diarrhoea coincided with rotavirus and coronavirus excretion. These calves lost six to seven per cent body weight. In further experiments calves were fed ‚Äúpositive‚Äù colostrum (from a pool collected on a Dutch dairy farm) for two days. Antibody titres of this pool against rotavirus and bovine coronavirus were as expected for mixed first‚Äêday colostrum of dairy cows under the Dutch conditions. One out of three control calves fed colostrum from this pool developed severe diarrhoea after challenge on day 6; the others only passed somewhat loose or yellow faeces for a few days. The first calf shed both viruses, the last two either rotavirus or coronavirus. Weight losses were limited or did not occur. More severe diarrhoea was observed in six vaccinated calves, three of which were challenged on day 6 and three on day 8. None of these calves excreted rotavirus or coronavirus before the challenge. Two to four days after the challenge all six developed diarrhoea, the beginning of which coincided with the start of rotavirus excretion. In three calves coronavirus excretion was also found, but this started a few days later. The calves challenged on day 6 were less severely affected than those challenged on day 8; body weight losses averaged four and eight per cent, respectively. These results show that effective oral vaccination of calves against diarrhoea induced by rotavirus or bovine coronavirus may be blocked by specific antibodies present in colostrum and thereby confirm an earlier hypothesis based on observations in the field. Laboruntersuchungen zur oralen Impfung von K√§lbern gegen Rotavirus‚Äê und Coronavirus‚Äêbedingten Durchfall Die Wirksamkeit einer oralen Impfung von K√§lbern mit einer modifizierten Lebendvakzine (Scourvax¬Æ‚Äê2, Smith Kline) gegen Rotavirus und/oder Coronavirus‚Äêbedingten Durchfall wurde unter kontrollierten Bedingungen getestet. Die K√§lber wurden eine Stunde nach der ersten F√ºtterung geimpft. Die Testinfektion erfolgte mit einer Mischung aus virulentem bovinem Rota‚Äê und Coronavirus. Ein Teil der K√§lber erhielt Kolostrum, welches keine Antik√∂rper gegen beide Viren enthielt. Drei Kontrollk√§lber aus dieser Gruppe entwickelten zwei bis drei Tage nach Testinfektion am 6. Lebenstag schwere Durchfallsymptome. Die Durchfalldauer betrug 5‚Äî12 Tage. Die K√§lber verloren im Durchschnitt 12,5 % an K√∂rpergewicht. Alle drei Tiere schieden Rota‚Äê und Coronavirus aus. Im Gegensatz dam wurde bei zwei geimpften K√§lbern nach Testinfektion am 6. Lebenstag kein Durchfall beobachtet. Nach der Impfung schied ein Kalb Rotavirus aus, das andere Rota‚Äê und Coronavirus. Nach der Testinfektion wurde jedoch keine Virusausscheidung mehr beobachtet. Drei andere K√§lber, die nicht streng isoliert gehalten wurden, bekamen innerhalb von 3 Tagen nach der Impfung Durchfall und schieden gleichzeitig Rota‚Äê und Coronavirus aus. Diese K√§lber verloren 6‚Äî7 % an K√∂rpergewicht. Ein anderer Teil der Versuche wurde an K√§lbern durchgef√ºhrt, die zwei Tage lang Antik√∂rper‚Äêhaltiges Kolostrum bekommen hatten. Dieser Kolostrum‚Äê‚ÄûPool‚Äù enthielt Antik√∂rper gegen beide Viren in einer f√ºr die holl√§ndischen Betriebe typischen Titerh√∂he. Eines von drei Kontrollk√§lbern, die mit diesem Kolostrum gef√ºttert wurden, bekam nach der Testinfektion am 6. Lebenstag schweren Durchfall und schied beide Viren aus. Die beiden anderen K√§lber zeigten nur leichte Durchfallsymptome √ºber einige Tage und schieden nur jeweils Rota‚Äê oder Coronavirus aus. Gewichtsverluste waren gering oder nicht vorhanden. Schwerere Durchfallsymptome wurden dagegen bei 6 geimpften Tieren beobachtet. Drei dieser Tiere wurden am 6. Lebenstag und drei am 8. Lebenstag testinfiziert. Keines dieser Tiere schied Rotavirus oder Coronavirus vor der Testinfektion aus. Zwei bis vier Tage nach der Testinfektion bekamen jedoch alle sechs Tiere Durchfall und schieden Rotavirus aus. Drei Tiere schieden einige Tage sp√§ter zus√§tzlich Coronavirus aus. K√§lber, die am 6. Lebenstag testinfiziert wurden, erkrankten weniger stark als am 8. Lebenstag testinfizierte Tiere. Die Gewichtsverluste betrugen 4 bzw. 8 %. Die Ergebnisse zeigen, da√ü eine erfolgreiche aktive Impfung von K√§lbern gegen Rotaoder Coronavirus induzierten Durchfall durch spezifische Kolostrumantik√∂rper verhindert werden kann. Damit werden fr√ºhere Beobachtungen best√§tigt, die auf Feldstudien basierten. Recherches de laboratoire sur la vaccination orale de veaux contre la diarrh√©e √† Rotavirus et sÃÄ Coronavirus L'efficacit√© d'un vaccin oral pour des veaux avec un vaccin vivant modifi√© (Scourvax¬Æ‚Äê2, Smith Kline) contre la diarrh√©e √† Rotavirus et/ou √† Coronavirus a √©t√© test√©e dans des conditions cont√¥bl√©es. Les veaux ont √©t√© vaccin√©s une heure apr√©s le premier repas. L'infection‚Äêtest a √©t√© faite avec un m√©lange de Rota‚Äê et de Coronavirus virulents bovins. Une partie des veaux ont re√ßu du colostrum qui ne contenait pas d'anticorps contre les deux virus. Trois veaux de contr√¥le de ce groupe ont d√©velopp√© de graves sympt√¥mes de diarrh√©e deux √† trois jours apr√®s l'infection‚Äêtest, au 6√®me jour de vie. La dur√©e de la diarrh√©e fut de 5‚Äî12 jours. Les veaux ont perdu en moyenne 12,5 % du poids. Les trois veaux excr√©t√®rent Rota‚Äê et Coronavirus. On n'a pas observ√© par contre de diarrh√©e au 6√®me jour de vie apr√®s une infection‚Äêtest chez deux veaux vaccin√©s. Un veau a excr√©t√© du Rotavirus et un autre Rota‚Äê et Coronavirus apr√®s la vaccination. Aucune excr√©tion virale n'a √©t√© observ√©e apr√®s l'infection‚Äêtest. Trois autres veaux qui n'avaient pas √©t√© strictement isol√©s ont fait une diarrh√©e dans les trois jours suivant la vaccination et ont excr√©t√© Rota‚Äê et Coronavirus. Ces veaux ont perdu 6‚Äî7 % de leur poids. Une autre partie de l'essai a √©t√© faite chez des veaux qui avaient re√ßu durant deux jours du colostrum avec des anticorps. Ce ¬´pool¬ª‚Äêcolostrum contenait des anticorps contre les deux virus avec un titre typique pour l'exploitation hollandaise. Un des trois veaux de contr√¥le ayant re√ßu ce colostrum a fait une grave diarrh√©e au 6√®me jour apr√®s l'infection‚Äêtest et a excr√©t√© les deux virus. Les deux autres veaux ne d√©velopp√®rent que de l√©gers sympt√¥mes de diarrh√©e durant quelques jours et excr√©t√®rent seulement soit Rota‚Äê soit Coronavirus. Les pertes de poids furent minimes ou inexistantes. De graves sympt√¥mes de diarrh√©e ont √©t√© par contre observ√©s chez 6 animaux vaccin√©s. Trois veaux ont subi une infection‚Äêtest au 6√©me et trois au 8√©me jour de vie. Aucune de ces b√™tes n'a excr√©t√© du Rotavirus ou du Coronavirus avant l'infection‚Äêtest. Tous les six veaux ont fait une diarrhie 2 √† 4 jours apresÃÄ l'infection‚Äêtest et excr√©t√®rent du Rotavirus. Trois animaux excr√©t√®rent en plus du Coronavirus quelques jours plus tard. Les veaux infect√©s au 6√®me jour de vie furent moins fortement atteints que les veaux infect√©s au 8√®me jour de vie. Les pertes de poids furent respectivement de 4 et 8 %. Les r√©sultats montrent qu'une vaccination active valable des veaux contre la diarrh√©e √† Rota‚Äê et Coronavirus peut √™tre inhib√©e par des anticorps sp√©cifiques du colostrum. Des observations ant√©rieures, bas√©es sur des √©tudes dans le terrain, sont ainsi confirm√©es. Experimentos de laboratorio sobre la vacunaci√≥n oral de terneros contra la diarrea inducida por rotavirus o coronavirus Con una vacuna viva modificada (Scourvax¬Æ‚Äê2, Smith Kline) se contrast√≥, bajo condiciones controladas, la eficacia de una vacunaci√≥n oral en terneros contra la diarrea condicionada por rotavirus y/o coronavirus. Los terneros fueron vacunados una hora despu√©s de recibir la primera alimentaci√≥n. La infecci√≥n de prueba se llev√≥ a cabo con una mezcla de rotavirus y coronavirus bovinos virulentos. Una parte de los terneros recibi√≥ calostro que no conten√≠a anticuerpos frente a ambos virus. Tres terneros testigos de este grupo desarrollaron s√≠ntomas graves de diarrea dos hasta ires d√≠as despu√©s de la infecci√≥n de prueba en el d√≠a 6¬∞ de vida. La duraci√≥n de la diarrea fue de 5‚Äî12 d√≠as. Los terneros perdieron como media 12.5 % de peso corporal. Todos los tres animales eliminaron rota y coronavirus. Por el contrario, en dos terneros vacunados no se observ√≥ diarrea despu√©s de la infecci√≥n de prueba el d√≠a 6¬∞ de vida. Tras la vacunaci√≥n elimin√≥ un ternero rotavirus, el otro rotavirus y coronavirus. Sin embargo, despu√©s de la infecci√≥n de prueba no se observ√≥ ya ninguna eliminaci√≥n de virus. Otros tres terneros, los cuales no hab√≠an sido aislados de modo riguroso, tuvieron diarrea en el plazo de 3 d√≠as tras la vacunaci√≥n y eliminaron al mismo tiempo rota y coronavirus. Estos terneros perdieron 6‚Äî7 % de peso corporal. Otra parte de los ensayos se llev√≥ a cabo con terneros que hab√≠an recibido durante dos d√≠as calostro que conten√≠a anticuerpos. Este fondo com√∫n de calostro comprend√≠a anticuerpos contra ambos virus con un nivel de t√≠tulo t√≠pico para explotaciones holandesas. Uno de los tres terneros testigos alimentados con este calostro sufri√≥ una diarrea grave y eliminaba ambos virus tras la infecci√≥n de prueba en el d√≠a 6¬∞ de vida. Los restantes dos terneros solo mostraban s√≠ntomas ligeros de diarrea a lo largo de algunos d√≠as y cada vez no eliminaban m√†s que rotavirus o coronavirus. Las p√©rdidas de peso eran escasas o no las hubo. En cambio, se observaron s√≠ntomas graves de diarrea en 6 animales vacunados. Tres de estos animales se infectaron de prueba el d√≠a 6¬∞ y tres el d√≠a 8¬∞ de vida. Ninguno de estos animales hab√≠a eliminado rota o coronavirus antes de iniciarse la infecci√≥n de prueba. Sin embargo, dos hasta cuatro d√≠as despu√©s de la infecci√≥n de prueba padecieron diarrea todos los seis animales, eliminando rotavirus. Tres animales difundieron aditivamente unos d√≠as m√°s tarde coronavirus. Los terneros que fueron infectados el d√≠a 6¬∞ enfermaron con gravedad menor que los animales infectados el d√≠a 8¬∞. Las p√©rdidas de peso fueron del orden de un 4 % y 8 %, resp. Muestran los resultados obtenidos que una vacunaci√≥n activa eficaz en terneros frente a la diarrea inducida por rotavirus o coronavirus se puede impedir por medio de anticuerpos calostrales espec√≠ficos. Con eso se confirman observaciones hechas anteriormente, las cuales se basaban en estudios campales. ¬© 1985 Blackwell Verlag GmbH
            </div>
        
            <div style="margin-bottom: 1em;">
                <span class="var">keywords</span>
                <span class="value">
                    
                    
                        
                        <a href="/topics/weight-loss.html"><span class="keyword">üîó&nbsp;weight loss (39)</span></a>
                    
                        
                        <a href="/topics/bovine-coronavirus.html"><span class="keyword">üîó&nbsp;bovine coronavirus (221)</span></a>
                    
                </span>
            </div>
        
            <div style="margin-bottom: 1em;">
                <div>
                    <span class="var">author</span>
                    <span class="value">
                        
                        
                            <a href="/authors/de-leeuw-p-w.html">üë§&nbsp;De Leeuw, P. W.</a>
                        
                            <a href="/authors/tiessink-j-w-a.html">üë§&nbsp;Tiessink, J. W.A.</a>
                        
                    </span>
                </div>

                <div>
                    <span class="var">year</span>
                    <span class="value">‚è∞ 1985</span>
                </div>

                <div>
                    <span class="var">journal</span>
                    <span class="value">
                        <a href="/journals/zentralblatt-f√ºr-veterin√§rmedizin-reihe-b.html">üìö Zentralblatt f√ºr Veterin√§rmedizin Reihe B</a>
                    </span>
                </div>
        
                <div>
                    <span class="var">issn</span>
                    <span class="value">üóÑ 14390450 09312021</span>
                </div>
               
                <div>
                    <span class="var">volume</span>
                    <span class="value">32</span>
                </div>
        
                <div>
                    <span class="var">number</span>
                    <span class="value">1-10</span>
                </div>
        
                <div>
                    <span class="var">page</span>
                    <span class="value">55-64</span>
                </div>
        
                <div>
                    <span class="var">doi</span>
                    <span class="value"><a href="http://dx.doi.org/10.1111/j.1439-0450.1985.tb01937.x">üìÑ 10.1111/j.1439-0450.1985.tb01937.x</a></span>
                </div>
        
                <div>
                    <span class="var">citedbycount</span>
                    <span class="value">7</span>
                </div>
        
            </div>
        
            <div>
                <span class="var">download</span>
                <span class="value"><a href="../bib/deleeuw1985laboratorydiarrhoea.bib">üîñ [BibTeX]</a></span>
            </div>
        
        </div>

    </div>
 
  </article>
 </div> </div> <footer class="site-footer"> <div class="wrapper"> <!-- <h2 class="footer-heading">CoV Index</h2> --> <div class="footer-col-wrapper"> <div class="footer-col footer-col-1"> <ul class="contact-list"> <!-- <li>CoV Index</li> --> <li> <a class="outbound" href="http://localhost:4000"><span class="icon icon--www"><svg xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:cc="http://creativecommons.org/ns#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:svg="http://www.w3.org/2000/svg" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 14.17475 14.17475" height="14.17475" width="14.17475" xml:space="preserve" version="1.1" id="svg4244"><metadata id="metadata4250"><rdf:RDF><cc:Work rdf:about=""><dc:format>image/svg+xml</dc:format><dc:type rdf:resource="http://purl.org/dc/dcmitype/StillImage" /><dc:title></dc:title></cc:Work></rdf:RDF></metadata><defs id="defs4248"><clipPath id="clipPath4258" clipPathUnits="userSpaceOnUse"><path id="path4260" d="m 0,11.34 11.34,0 L 11.34,0 0,0 0,11.34 Z" /></clipPath></defs><g transform="matrix(1.25,0,0,-1.25,0,14.17475)" id="g4252"><g style="stroke:#58928a;stroke-opacity:1" transform="matrix(0.97909434,0.20340668,-0.20340668,0.97909434,1.2718042,-1.0347843)" id="g4254"><g style="stroke:#58928a;stroke-opacity:1" clip-path="url(#clipPath4258)" id="g4256"><g style="stroke:#58928a;stroke-opacity:1" transform="translate(0.563,5.6699)" id="g4262"><path id="path4264" style="fill:none;stroke:#58928a;stroke-width:1;stroke-linecap:butt;stroke-linejoin:miter;stroke-miterlimit:10;stroke-dasharray:none;stroke-opacity:1" d="m 0,0 c 0,2.82 2.287,5.107 5.107,5.107 2.82,0 5.107,-2.287 5.107,-5.107 0,-2.82 -2.287,-5.107 -5.107,-5.107 C 2.287,-5.107 0,-2.82 0,0 Z" /></g><g style="stroke:#58928a;stroke-opacity:1" transform="translate(8.4111,5.6704)" id="g4266"><path id="path4268" style="fill:none;stroke:#58928a;stroke-width:1;stroke-linecap:butt;stroke-linejoin:miter;stroke-miterlimit:10;stroke-dasharray:none;stroke-opacity:1" d="m 0,0 c 0,2.819 -1.259,5.106 -2.811,5.106 -1.552,0 -2.811,-2.287 -2.811,-5.106 0,-2.823 1.259,-5.108 2.811,-5.108 C -1.259,-5.108 0,-2.823 0,0 Z" /></g><g style="stroke:#58928a;stroke-opacity:1" transform="translate(5.6699,10.647)" id="g4270"><path id="path4272" style="fill:none;stroke:#58928a;stroke-width:1;stroke-linecap:butt;stroke-linejoin:miter;stroke-miterlimit:10;stroke-dasharray:none;stroke-opacity:1" d="M 0,0 0,-9.855" /></g><g style="stroke:#58928a;stroke-opacity:1" transform="translate(0.563,5.6699)" id="g4274"><path id="path4276" style="fill:none;stroke:#58928a;stroke-width:1;stroke-linecap:butt;stroke-linejoin:miter;stroke-miterlimit:10;stroke-dasharray:none;stroke-opacity:1" d="M 0,0 10.214,0" /></g></g></g></g></svg></span> <span class="username">http://localhost:4000</span></a> </li> </ul> </div> <div class="footer-col footer-col-2"> <img src="data:image/png;base64,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" width="50" style="margin-top: 6px;" /> <ul class="social-media-list"> </ul> </div> <div class="footer-col footer-col-3"> <div>CoV Index is the map of Coronavirus Science. </div> <!-- <div id="blogpost"> Latest article: <a href="/blog/initial-launch-of-cov-index.html">Initial launch of CoV Index</a> <span class="post-meta">Mar 24, 2020</span> </div> --> </div> </div> </div> <div id="content-license"> <a href="/license/">cc 2020 Ian Dennis Miller</a> </div> </footer> <script data-goatcounter="https://covindex.goatcounter.com/count" async src="//gc.zgo.at/count.js"></script> </body> </html>
